New research from The Jackson Laboratory highlights the functional mechanisms that may underlie ME/CFS
Retrieved on:
Thursday, February 9, 2023
Biomarker, Fatigue, Physician, Post-exertional malaise, Blood, Cell Host & Microbe, JAX, Dysbiosis, National Institute of Neurological Disorders and Stroke, DSM-IV codes, Viral, Diagnosis, Bangladesh Technical Education Board, NIH, Pain, NINDS, Multi-Omics Profiling Expression Database, Metabolism, Patient, Myalgia, Ageing, Jackson Laboratory, Tryptophan, Chronic fatigue syndrome, Fibromyalgia, Research, Betaine, Associate, Immune system, Plasma, Disease, ME/CFS, COVID, COVID-19, Classification, Nursing, Vaccine, Pharmaceutical industry, Stroke
Jackson Laboratory (JAX) Professor Derya Unutmaz , M.D., and Associate Professor Julia Oh , Ph.D., have teamed with ME/CFS physicians and other experts to help remove the obstacles.
Key Points:
- Jackson Laboratory (JAX) Professor Derya Unutmaz , M.D., and Associate Professor Julia Oh , Ph.D., have teamed with ME/CFS physicians and other experts to help remove the obstacles.
- Their studies have involved exhaustive analyses of immune cells and metabolites in their blood, and the microbes in their bodies.
- Previous research has indicated that altered gut microbiota may underlie the gastrointestinal problems associated with ME/CFS.
- Progress in either long COVID or ME/CFS research may therefore provide diagnostic and therapeutic insight for both conditions.